- Home
- PHAT vs ASC Comparison
PHAT vs ASC Comparison
Compare PHAT & ASC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PHAT
- ASC
- Stock Information
- Founded
- PHAT 2018
- ASC 2010
- Country
- PHAT United States
- ASC Bermuda
- Employees
- PHAT N/A
- ASC N/A
- Industry
- PHAT Biotechnology: Pharmaceutical Preparations
- ASC Marine Transportation
- Sector
- PHAT Health Care
- ASC Consumer Discretionary
- Exchange
- PHAT Nasdaq
- ASC Nasdaq
- Market Cap
- PHAT 465.0M
- ASC 437.8M
- IPO Year
- PHAT 2019
- ASC 2013
- Fundamental
- Price
- PHAT $5.67
- ASC $10.04
- Analyst Decision
- PHAT Strong Buy
- ASC Buy
- Analyst Count
- PHAT 4
- ASC 3
- Target Price
- PHAT $23.00
- ASC $20.00
- AVG Volume (30 Days)
- PHAT 1.0M
- ASC 761.3K
- Earning Date
- PHAT 03-06-2025
- ASC 02-13-2025
- Dividend Yield
- PHAT N/A
- ASC 9.47%
- EPS Growth
- PHAT N/A
- ASC 12.92
- EPS
- PHAT N/A
- ASC 3.06
- Revenue
- PHAT $26,270,000.00
- ASC $405,784,000.00
- Revenue This Year
- PHAT $7,453.23
- ASC N/A
- Revenue Next Year
- PHAT $226.38
- ASC N/A
- P/E Ratio
- PHAT N/A
- ASC $3.28
- Revenue Growth
- PHAT N/A
- ASC 2.48
- 52 Week Low
- PHAT $5.21
- ASC $10.02
- 52 Week High
- PHAT $19.71
- ASC $23.44
- Technical
- Relative Strength Index (RSI)
- PHAT 39.59
- ASC 28.96
- Support Level
- PHAT $5.50
- ASC $10.22
- Resistance Level
- PHAT $6.21
- ASC $11.95
- Average True Range (ATR)
- PHAT 0.40
- ASC 0.48
- MACD
- PHAT 0.07
- ASC -0.15
- Stochastic Oscillator
- PHAT 38.69
- ASC 0.66
About PHAT Phathom Pharmaceuticals Inc.
Phathom Pharmaceuticals Inc operates as a clinical-stage biopharmaceutical company. The firm is focused on developing and commercializing novel treatments for gastrointestinal, or GI, diseases. Its product comprises vonoprazan, an oral small-molecule potassium competitive acid blocker medicine that blocks acid secretion in the stomach. Vonoprazan shows rapid, potent, and durable anti-secretory effects and has demonstrated clinical benefits in the treatment of gastroesophageal reflux disease, and in combination with antibiotics for the treatment of Helicobacter pylori infection.
About ASC Ardmore Shipping Corporation
Ardmore Shipping Corp provides seaborne transportation of petroleum products and chemicals world-wide to oil majors, national oil companies, oil and chemical traders, and chemical companies, with its modern, fuel-efficient fleet of mid-size product and chemical tankers. The Company operates its business in one operating segment, the transportation of refined petroleum products and chemicals.